Recent Advances in Diagnostic and Therapeutic Strategies for Diabetes Mellitus: A Comprehensive Review

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Its global burden continues to escalate, affecting over 540 million individuals as of 2024. This comprehensive review highlights recent developments in the diagnosis and management of diabetes, focusing on both conventional and emerging approaches. Diagnostic innovations include continuous glucose monitoring systems, lab-on-a-chip devices, wearable biosensors, and novel biomarkers such as microRNAs and adipokines, which offer enhanced sensitivity and real-time glycemic profiling. Therapeutically, advancements extend beyond traditional pharmacological interventions—such as insulin, metformin, and sulfonylureas—to include incretin-based therapies, SGLT2 inhibitors, and cardio-renal protective agents. In parallel, plant-based interventions and phytochemicals derived from Momordica charantia, Gymnema sylvestre, Tinospora cordifolia, and others have shown significant antidiabetic activity via multifaceted mechanisms including β-cell preservation, insulin mimetic action, and antioxidative stress modulation. The incorporation of nanotechnology, gene therapy, and stem cell approaches represents a transformative frontier in diabetes care, aiming at disease modification rather than symptomatic control. Despite these promising strides, challenges remain in the form of affordability, health system integration, regulatory oversight, and the need for robust clinical validation, particularly for herbal and nanomedicine-based strategies. This review underscores the importance of a multidisciplinary, patient-centered approach to diabetes management, integrating evidence-based innovations with public health strategies to curb the global impact of the disease.